Welcoming Tim Denison to ONWARD Medical’s Board
ONWARD Medical N.V., a leading force in neurotechnology dedicated to restoring movement and independence for individuals with spinal cord injuries and related challenges, has some exciting leadership updates. Recently, Tim Denison, PhD, a prominent name in the field of neurotechnology, has joined the company's Board of Directors. This move comes as the company continues its journey to innovate and expand its therapeutic offerings.
About Tim Denison
Dr. Tim Denison brings a wealth of experience to ONWARD Medical. He currently serves as Professor of Clinical Neurosciences at the University of Oxford and has an impressive background, having served as Vice President of Research and Core Technologies at Medtronic. Furthermore, he is the co-founder and Chief Engineer of Amber Therapeutics, a company that focuses on neurotechnology solutions, specifically for urinary incontinence. His robust educational background includes a Ph.D. in Electrical Engineering from MIT and an MBA from the University of Chicago.
Changes to the Board of Directors
In addition to welcoming Dr. Denison, ONWARD Medical has announced that Professor Gregoire Courtine, who co-founded the company, will transition from his role on the Board to focus on his new responsibilities as Director of the Neuro-X Institute. Courtine will continue contributing to ONWARD, ensuring that his valuable insights and expertise remain part of the company as a Science Advisor.
The Impact of New Leadership
Denison’s appointment is seen as pivotal for the company as it aims to enhance its product line, which includes the innovative ARC Therapy system. This advancement nurtures hope and independence for individuals dealing with spinal challenges.
The Neuro-X Institute: A Collaboration Hub
The Neuro-X Institute that Professor Courtine is leading brings together more than 200 scientific collaborators to fuse clinical neuroscience with engineering and computational techniques. The interdisciplinary approach aims to expedite the development of therapies for neurological disorders, significantly aligning with ONWARD Medical’s mission.
Company Vision and Achievements
ONWARD Medical has been a trailblazer in the neurotechnology sphere, focusing on therapeutic solutions that enhance recovery and functionality for patients facing spinal cord injuries. Their flagship product, ARC Therapy, has received multiple Breakthrough Device Designations from the FDA, underlining its potential to redefine recovery prospects for patients.
Looking Ahead
As ONWARD Medical embraces Dr. Denison’s expertise along with Professor Courtine's ongoing contributions, the organization is poised for significant advancements in its therapeutic landscape. CEO Dave Marver expressed enthusiasm about Dr. Denison’s unique blend of academic and industry experience, which is expected to propel the company’s ongoing innovations in spinal cord therapies.
Recent Board Appointments
In light of these transitions, the company has also confirmed several other reappointments during its recent Annual General Meeting. Dave Marver will continue as CEO for an additional four years, ensuring stability within the executive branch as the company navigates its innovative journey.
Continued Leadership
With Ian Curtis reappointed as Non-Executive Director and Rob ten Hoedt formally ratified as the Chairman of the Board, ONWARD Medical is reinforcing its commitment to excellence in neurotechnology. These strategic decisions reflect the company’s vision for leading advancements in therapies that impact the quality of life for patients around the world.
About ONWARD Medical
Headquartered in the Netherlands, with a dedicated science center in Switzerland and operations in Boston, Massachusetts, ONWARD Medical is at the forefront of developing innovative neurotechnological therapies. The company’s dedication stems from years of empirical research and clinical trials, showcasing its commitment to enhancing the lives of those affected by spinal injuries.
Frequently Asked Questions
What is the main focus of ONWARD Medical?
ONWARD Medical focuses on pioneering therapies to restore movement and function for individuals with spinal cord injuries and other movement disabilities.
Who is Tim Denison?
Tim Denison, PhD, is a noted neurotechnology expert and has recently joined ONWARD Medical’s Board of Directors, bringing valuable expertise from academia and industry.
What role will Professor Courtine play going forward?
Professor Courtine will step down from the Board but will remain active in his capacity as Science Advisor to ONWARD Medical.
What is the ARC Therapy?
ARC Therapy is a targeted approach developed by ONWARD Medical that has received significant recognition from regulatory bodies as a breakthrough innovation for spinal recovery.
How can individuals stay updated on ONWARD Medical's advancements?
Individuals can complete a webform on ONWARD Medical’s website to receive regular updates about new technologies, research studies, and therapy availability.
